Pathological migrating intramural hematoma in stenting for carotid artery dissection: A ten-year consecutive cohort

Lizhang Chen1, Fayun Hu1, Shuju Dong2

  • 1Department of Neurology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China.

PubMed

Insights

Pathological migrating intramural hematoma (PMIH) occurs in 10.4% of carotid artery dissection stenting cases. Early intervention with angioplasty or stenting is crucial for managing new stenosis caused by PMIH to prevent ischemic events.

Area of Science:

  • Vascular Surgery
  • Interventional Neurology
  • Cardiovascular Research

Background:

  • Carotid artery dissection (CAD) is a significant cause of stroke.
  • Stenting is a treatment option for CAD, but potential complications require study.
  • Pathological migrating intramural hematoma (PMIH) is a rare complication of stenting.

Purpose of the Study:

  • To investigate the incidence of PMIH in patients undergoing stenting for CAD.
  • To identify factors associated with PMIH.
  • To establish a management strategy for PMIH.

Main Methods:

  • Retrospective analysis of 67 CAD patients treated with stenting over a 10-year period.
  • Evaluation of PMIH incidence, timing, location, and associated factors.
  • Review of management strategies and clinical outcomes.

Main Results:

  • PMIH occurred in 7 patients (10.4%) with a median symptom-to-stenting time of 5 days.
  • PMIH was observed in both proximal (4 cases) and distal (3 cases) stent segments.
  • All patients presented with new stenosis; no dissecting aneurysms were noted. Proper management led to no clinical complications.

Conclusions:

  • The phenomenon of PMIH exists in carotid artery dissection stenting.
  • Early treatment with angioplasty or stenting is recommended for moderate to severe stenosis caused by PMIH.
  • Timely intervention is essential to prevent further ischemic events.
Abstract

Related Concept Videos